Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Cell, Circulating”

713 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 713 results

Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 24
Not applicableLooking for participantsNCT05831631
What this trial is testing

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Who this might be right for
Brain Tumor, PrimaryBrain Tumor - Metastatic
Pietro Mortini, MD, Prof. 200
Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Not applicableStudy completedNCT00156273
What this trial is testing

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center 69
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Testing effectiveness (Phase 2)UnknownNCT01565837
What this trial is testing

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

Who this might be right for
Melanoma
Wolfram Samlowski 50
Not applicableStudy completedNCT02948751
What this trial is testing

Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

Who this might be right for
Breast CancerLeptomeningeal Metastasis
Columbia University 14
Not applicableNot Yet RecruitingNCT07398456
What this trial is testing

Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas

Who this might be right for
Colorectal Cancer (CRC) Screening
Baylor Research Institute 5,500
Not applicableUnknownNCT05208372
What this trial is testing

Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer

Who this might be right for
Stomach NeoplasmsMetastasis
First Hospital of China Medical University 200
Not applicableUnknownNCT02005913
What this trial is testing

A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence

Who this might be right for
Colorectal Cancer (CRC)
National Taiwan University Hospital 600
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)UnknownNCT03058809
What this trial is testing

Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood

Who this might be right for
Metastatic Cancer
Viatar LLC 100
Not applicableActive Not RecruitingNCT05818865
What this trial is testing

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Who this might be right for
Neoplasm Malignant
National Cancer Institute, Naples 47
Not applicableLooking for participantsNCT05227534
What this trial is testing

Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)

Who this might be right for
CancerEarly Detection of CancerCirculating Cell-free DNA
Guangzhou Burning Rock Dx Co., Ltd. 12,500
Testing effectiveness (Phase 2)Looking for participantsNCT04966663
What this trial is testing

Using ctDNA to Determine Therapies for Lung Cancer

Who this might be right for
Non Small Cell Lung CancerComplete Surgical ResectionCirculating Tumor DNA
University Health Network, Toronto 66
Not applicableLooking for participantsNCT07303712
What this trial is testing

Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

Who this might be right for
Hepatocellular Carcinoma (HCC)
Palo Alto Veterans Institute for Research 12
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT05245071
What this trial is testing

Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sanofi 22
Not applicableLooking for participantsNCT04902937
What this trial is testing

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

Who this might be right for
Tumor Cell, Circulating
University of Jena 200
Not applicableStudy completedNCT00588510
What this trial is testing

Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction

Who this might be right for
Osteosarcoma
Memorial Sloan Kettering Cancer Center 59
Next Page